涓浗鑽悊瀛︿細
浼氬憳涓績 | 鑱旂郴鎴戜滑
 
棣栭〉

鍥介檯钁楀悕鑽悊瀛﹀ Vanhoutte鏁欐巿閫濅笘

鏉ユ簮锛氫腑鍥借嵂鐞嗗浼氱綉銆銆銆 銆瀛楀彿:[] [] []    鎵撳嵃
 


鍥介檯钁楀悕鑽悊瀛﹀锛屼韩瑾変笘鐣岀殑琛绠$敓鐗╁鍓嶈緢Paul Michel Georges Vanhoutte鏁欐巿鍥犵梾涓嶅垢浜2019823鏃ュ湪宸撮粠閫濅笘锛屼韩骞79宀併

The discipline of pharmacology and vascular biology lost Dr. Paul Michel Georges Vanhoutte. He died at the age of 79 in Paris, France on August 23rd , 2019.

Vanhoutte鏁欐巿1940骞村嚭鐢熶簬姣斿埄鏃讹紝鍒嗗埆鍦ㄦ牴鐗瑰ぇ瀛﹀強瀹夌壒鍗櫘澶у鑾峰緱瀛﹀+銆佺澹強鍖诲鍗氬+瀛︿綅銆1969骞磋捣鍏堝悗鍦ㄦ牴鐗瑰ぇ瀛﹀拰缇庡浗姊呭ゥ璇婃墍(Mayo Clinic)浠诲姪鐞嗘暀鎺堛佸壇鏁欐巿銆佹暀鎺堛1981-1989浠绘濂ュ尰瀛︿腑蹇冪敓鐞嗗鍙婅嵂鐞嗗鏁欐巿锛1989-1995浠昏礉鍕掑尰瀛﹂櫌鑽悊瀛﹀強鐢熺悊瀛︽暀鎺堛佸疄楠屾不鐤椾腑蹇冧富浠汇1992-2002骞翠换娉曞浗鏂界淮闆呯爺绌堕櫌锛Institut De Recherches Servier锛夌爺鍙戝壇鎬昏銆2003-2011骞存媴浠婚娓ぇ瀛︾壒鑱樿闂暀鎺堛佺敓鐗╄嵂瀛︾爺鍙戜腑蹇冧富浠汇佽嵂鐞嗙郴涓讳换鏁欐巿銆備粬鐢变簬鍗撹秺鐨勬垚灏卞厛鍚庡彈閭鎷呬换涓栫晫澶氫釜鍥藉澶у鍙婂鏈満鏋勭殑瀹㈠骇鏁欐巿锛屽叾涓寘鎷潪娲插崲鏃鸿揪鍥界珛澶у锛1967锛夈佹尝鍏扮瀛﹂櫌锛1979锛夈佹矙鐗瑰浗鐜嬪ぇ瀛︺備粬鎷呬换澶氫釜鍥藉澶у鍜岀鐮旀満鏋勭殑鑽h獕鏁欐巿銆佸搴ф暀鎺堟垨鍥介檯绉戝椤鹃棶锛屽寘鎷寳浜ぇ瀛︺佸寳浜崗鍜屽尰瀛﹂櫌銆佷腑鍥藉尰瀛︾瀛﹂櫌鑽墿鐮旂┒鎵銆佷腑鍥芥捣娲嬪ぇ瀛︺佺浜屽啗鍖诲ぇ瀛︺佷腑鍥界瀛﹂櫌涓婃捣鑽墿鐮旂┒鎵銆佹硶鍥芥柉鐗规媺鏂牎澶у銆佸崡涓归害澶у銆侀┈鏉ヤ簹澶у銆侀煩鍥藉叏鍖楀ぇ瀛︺佺憺澹嫃榛庝笘澶у绛夈

Dr. Vanhoutte was born in 1940 in Belgium, where he obtained his degrees at the University of Gent (B.S., M.S., and M.D.) and the University of Antwerpen (equivalent to Ph.D.). He received his postdoctoral training at the University of Gent and at the Mayo Clinic (Rochester, MN, USA). His academic career started at the University of Gent (Assistant, 1969-1971), followed by the Mayo Clinic (Research Associate, 1972-1973), the University of Antwerpen (Belgium), from Associate Professor to full Professor and Head of the Department of Pharmacology, 1973-1981), again the Mayo Clinic (Professor of Physiology and Pharmacology, 1981-1989) and Baylor College of Medicine (Houston TX, USA, Professor of Medicine, Pharmacology and Physiology, and Director Center for Experimental Therapeutics, 1989-1995). From 1992 to 2002, Dr. Vanhoutte was Vice-President R&D, and Director of Discovery Research at the Institut de Recherches Internationales Servier, in Courbevoie (Paris, France). During his tenure as Director of Discovery Research at Servier, he supervised the discovery and preclinical development of drugs designed for the treatment of cardiovascular diseases, diabetes, obesity, central nervous system disorders, cancer and osteoarthritis. From 2003 to 2006 he was Distinguished Visiting Professor and Director of the BioPharmaceutical Development Centre, at the University of Hong Kong. From 2006 to 2011 he was the Head of the Department of Pharmacology, University of Hong Kong. He was Honorary Professor at the Peking Union Medical College (Beijing), the Institute of Materia Medica of the Chinese Academy of Medical Sciences, the Ocean University of China, the Second Military Medical University in Shanghai and the Shanghai Institute of Materia Medica. He is also Visiting Professor and International Scientific Advisor at the Peking University Health Sciences Center and Visiting Professor at the University of South Denmark, the University of Strasbourg (France), the University of Malaya (Malaysia), Chonbuk National University in Jeonju (South-Korea) and the University of Zurich (Switzerland).

Vanhoutte鏁欐巿鏄娲茬瀛﹂櫌闄㈠+锛屽反榛庡浗瀹惰嵂瀛﹂櫌闄㈠+锛屾瘮鍒╂椂鍖诲绉戝闄㈤櫌澹互鍙婂反瑗垮尰瀛︾瀛﹂櫌鑽h獕闄㈠+銆傜編鍥藉唴绉戝尰甯堝崗浼氥佺編鍥界敓鐞嗗浼氥佺編鍥藉績鑴忓崗浼氥佺編鍥戒复搴婄爺绌跺浼氥佺編鍥藉績鑴忕梾瀛﹀闄€佺編鍥借绠″闄€佺編鍥借嵂鐞嗗鍙婂疄楠屾不鐤楀浼氥佹瘮鍒╂椂鐢熺悊涓庤嵂鐞嗗浼氥佽嫳鍥借嵂鐞嗗浼氥佹硶鍥借嵂鐞嗗浼氬強娆ф床蹇冭剰瀛︿細鐨勪細澹傞娓嵂鐞嗗浼氬墠浠讳富甯紝浜氭床琛绠$敓鐗╁浼氬垱浼氫富甯傛浘鎷呬换鍥介檯鍩虹涓庝复搴婅嵂鐞嗗鑱斿悎浼氾紙IUPHAR锛夌涔﹂暱銆佷富甯強鍏跺彈浣撳懡鍚嶅鍛樹細涓诲腑銆傛媴浠诲涓浗闄呭鏈潅蹇楀Journal of Cardiovascular Pharmacology涓荤紪锛 the American Journal of Physiology 锛堝績鑴忎笌寰幆鍒嗗唽锛夊壇涓荤紪锛CirculationCirculation ResearchHypertension涓浗鑽悊鏉傚織锛堣嫳鏂囷級绛夋湡鍒婄殑缂栧銆備粬鍙戣〃浜669绡囩爺绌惰鏂囥574绡囩患杩般佽瘎璁哄強钁椾綔绔犺妭銆備负鐢熺墿瀛︿笌鍖栧銆佽嵂鐞嗗鍙婁复搴婂尰瀛︿笁涓鍩熺殑楂樿寮曞鑰ISI锛岃鏂囨昏寮88643娆★紝H鎸囨暟涓143

Dr. Vanhoutte is member of the Academia Europea, the Academie Nationale de Pharmacie [Paris] and the Belgian Academy of Medicine, and an honorary member of the Brazilian Academy of Medicine. He is member of the American Association of Physicians, the American Society of Physiology, the American Heart Association(fellow), the American Society for Clinical Investigation (Emeritus), the American College of Cardiology (fellow), the American College of Angiology (fellow), the American Society for Pharmacology and Experimental Therapeutics, the Belgian Society for Physiology and Pharmacology, , the British Pharmacological Society (Honorary Fellow), the French Pharmacological Society and the European Society of Cardiology(fellow). He is the Past-President of the Hong Kong Pharmacology Society. Dr. Vanhoutte is the founder and Past-President of the Serotonin Club and of the Asian Society of Vascular Biology. He is honorary member of the Physiological Society (London), the Chinese Pharmacological Society, the German Society of Angiology and the Soci茅t茅 Française de Cardiologie. He chaired the the International Union of Basic and Clinical Pharmacology (IUPHAR) Committee for Receptor Nomenclature from 1989 to 1998. He was Secretary General of IUPHAR from 1998 to 2002, and President of the Union from 2002 to 2006.From 1989 to 2007, he was the Editor-in-Chief of the Journal of Cardiovascular Pharmacology. He has been Associate Editor of the American Journal of Physiology (Heart and Circulatory Physiology). He has been member of the Editorial Board of many scientific journals (e.g. Circulation, Circulation Research, Hypertension, Acta Pharmacologica Sinica). He has published 669 original research papers, and 574 editorials, reviews or chapters in books. Dr. Vanhoutte is a Highly Cited Researcher (ISI) in three categories: Biology & Chemistry, Pharmacology, and Clinical Medicine. His h-index is 124.

Vanhoutte鏁欐巿鎻ず浜嗗唴鐨粏鑳炲湪琛绠″姛鑳借皟鑺傚強鐤剧梾涓殑閲嶈浣滅敤銆備粬鎮夊績鍩瑰吇鎻愭惡鍚庤緢锛屾繁鍙楃埍鎴达紝琚獕涓鸿绠$敓鐗╁涔嬬埗銆傜編鍥藉疄楠岃嵂鐞嗗強娌荤枟瀛﹀浼氬拰鍥介檯浜旂緹鑹茶兒鐮旂┒浼氬潎璁剧珛浜嗕互浠栧懡鍚嶇殑Vanhoutte璁插骇銆備粬鍙戝姩鍒涚珛浜嗕腑鍥借嵂鐞嗗浼氭柦缁撮泤闈掑勾鑽悊瀛﹀濂栵紝闈掑勾鑽墿鍖栧濂栵紝杩勪粖宸叉湁鏁扮櫨浣嶉潚骞翠汉鑾峰銆備粬鍚屾椂涔熷湪涓浗浠庝簨琛绠$敓鐗╁鍜岃嵂鐞嗗鐮旂┒锛屽湪涓婃捣銆佽タ瀹夌瓑鍦版垚鍔熺粍缁囦簡澶氬眾浜氭床琛绠$敓鐗╁澶т細锛屽崗鍔╀腑鍥借嵂鐞嗗浼氱敵鍔炲苟鎴愬姛涓诲姙浜嗙鍗佷簲灞婁笘鐣岃嵂鐞嗗澶т細锛WCP2006锛夈備粬鏅氬勾浠嶄笉椤剧柌鍊︼紝闀块斿娉笌娆т簹涔嬮棿锛屼负浜氭床鍜屼腑鍥界殑鍖昏嵂瀛︾鐮旀暀鑲茬殑鍙戝睍鍙戞尌浜嗗法澶х殑鎺ㄥ姩浣滅敤銆傚湪201811鏈堜妇琛岀殑琛绠″尰瀛︾涓夊眾浼氳鏆ㄧ8灞婁簹娲茶绠$敓鐗╁澶т細涓婏紝Vanhoutte鏁欐巿鎶辩梾鍒颁笂娴峰叏绋嬪弬鍔犱簡浼氳骞跺仛浜嗗ぇ浼氭姤鍛婏紝浠ゆ垜浠繁鍙楁劅鍔ㄣ

Dr. Vanhoutte鈥檚 major scientific contribution has been to appreciate and analyze the importance of endothelial cells in the control of the underlying vascular smooth muscle in vascular health and disease, and to highlight the complexity of that regulation. He contributed greatly in cultivating the young talents. He established the Paul M. Vanhoutte Distinguished Lectureship in Vascular Pharmacology for American Society for Pharmacology and Experimental Therapeutics, and 鈥淧aul Vanhoutte Lecture鈥 in Serotonin Pharmacology for the International Society for Serotonin Research Council. He was one of the founders of the CNPHARS-Servier Young Investigator Awards in Pharmacology and CPA-Servier Prize for Young Investigators in Medicinal Chemistry. Hundreds of young scientists have been awarded and encouraged to pursue their career in medical research. He organized the scientific meeting of Asian Society for Vascular Biology in Xi鈥檃n and Shanghai. During Dr. Vanhoutte鈥檚 tenure of IUPHAR Secretary General and President, Chinese Pharmacological Society won the right to host the 15th World Congress on Pharmacology. It was successfully held in Beijing in 2006. In his later years, Dr. Vanhoutte travelled frequently between Europe and Asia, promoting the development of medical scientific research and education in China and Asia. Although suffered by diseases, Dr. Vanhoutte went to Shanghai to give a plenary lecture in the 8th Scientific Meeting of Asian Society for Vascular Biology, which deeply touched all the participants.

Vanhoutte鏁欐巿鏄腑鍥借嵂鐞嗗浼氱殑鑰佹湅鍙嬶紝浠栫殑閫濅笘鏄绠″尰瀛﹀強鑽悊瀛︾晫鐨勫法澶ф崯澶便傛垜浠劅婵骞剁紖鎬Vanhoutte鏁欐巿锛

Dr. Vanhoutte is an old friend of the Chinese pharmacology society. The Chinese Pharmacological Society suffered a significant loss with the passing of Dr. Paul M. Vanhoutte. He will forever be remembered and appreciated by us!

涓浗鑽悊瀛︿細
浜琁CP澶18017554鍙-2 | 浜叕缃戝畨澶 11010202007922鍙
2025 涓浗鑽悊瀛︿細 鐗堟潈鎵鏈 鏈粡鍏佽 涓嶅緱杞浇 | 鑱旂郴鎴戜滑 | 鎰忚鍙嶉
鍦板潃锛氬寳浜競瑗垮煄鍖哄崡绾矾鐢2鍙
閭斂缂栫爜锛100050
鍙嬫儏閾炬帴

涓浗鑽悊瀛︿細 寰俊浜岀淮鐮佸叕浼楀彿